ELV400.32+0.53%
ELV · US
1y range: 280.74 → 426.79 · as of 2026-08-14
AI digest — today
Elevance Health staat onder druk na lagere earnings- en revenue-forecasts van analisten ($6.18 EPS verwacht), ondanks een sterke koersperformance van +33,61% over 90 dagen. Tegelijkertijd vecht het bedrijf een rechtszaak uit tegen HHS/CMS over Medicare Star Ratings die naar eigen zeggen $115 miljoen aan bonusbetalingen hebben gekost.
Generated 2026-07-11 06:00
Recent material news
- Encompass Health Beats Q2 Earnings Estimates, Raises '26 View2026-08-07T15:47
- Pediatrix Medical Tops Q2 Earnings on Better Cash Collections2026-08-06T17:00
- Teladoc Health Q2 Earnings Beat Estimates on Integrated Care Strength2026-07-30T16:33
- ENSG Q2 Earnings Beat Estimates on Growing Occupancy, '26 View Raised2026-07-30T16:24
- Elevance Health Has Upside, But Not Yet A Buy2026-07-28T16:54
- Centene Q2 Earnings Beat Estimates on Increasing Premiums2026-07-28T16:04
- Tenet Healthcare Tops Q2 Earnings Estimates, Raises 2026 Outlook2026-07-27T19:11
Want this depth on every stock you watch?
ThickerPeek writes a daily AI digest on 165+ stocks, weekly theses, earnings briefings, and alerts — for €19/mo. Free tier available.
Not investment advice. ThickerPeek is a research tool. AI-written content is informational, not a buy/sell recommendation. Investment decisions are your own responsibility.